Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve

Kizuku Yamashita; Tomoyuki Fujita; Satsuki Fukushima; Yusuke Shimahara; Yuta Kume; Yorihiko Matsumoto; Naonori Kawamoto; Tatsuro Hitsumoto; Nobuyasu Ito; Yasuhiro Hamatani; Atsushi Okada; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Hideaki Kanzaki; Toshihisa Anzai; Satoshi Yasuda; Junjiro Kobayashi

doi:10.1253/circj.CJ-17-0851

Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve

Kizuku Yamashita, Tomoyuki Fujita, Satsuki Fukushima, Yusuke Shimahara, Yuta Kume, Yorihiko Matsumoto, Naonori Kawamoto, Tatsuro Hitsumoto, Nobuyasu Ito, Yasuhiro Hamatani, Atsushi Okada, Hiroyuki Takahama, Makoto Amaki, Takuya Hasegawa, Yasuo Sugano, Hideaki Kanzaki, Toshihisa Anzai, Satoshi Yasuda, Junjiro Kobayashi

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Background: The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve. Methods and Results: We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events. Conclusions: Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.

Original language	English
Pages (from-to)	289-292
Number of pages	4
Journal	Circulation Journal
Volume	82
Issue number	1
DOIs	https://doi.org/10.1253/circj.CJ-17-0851
Publication status	Published - 2018
Externally published	Yes

Keywords

Degenerated bioprosthesis
Transcatheter aortic valve implantation
Valve-in-valve

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1253/circj.CJ-17-0851

Cite this

Yamashita, K., Fujita, T., Fukushima, S., Shimahara, Y., Kume, Y., Matsumoto, Y., Kawamoto, N., Hitsumoto, T., Ito, N., Hamatani, Y., Okada, A., Takahama, H., Amaki, M., Hasegawa, T., Sugano, Y., Kanzaki, H., Anzai, T., Yasuda, S., & Kobayashi, J. (2018). Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve. Circulation Journal, 82(1), 289-292. https://doi.org/10.1253/circj.CJ-17-0851

Yamashita, K, Fujita, T, Fukushima, S, Shimahara, Y, Kume, Y, Matsumoto, Y, Kawamoto, N, Hitsumoto, T, Ito, N, Hamatani, Y, Okada, A, Takahama, H, Amaki, M, Hasegawa, T, Sugano, Y, Kanzaki, H, Anzai, T, Yasuda, S & Kobayashi, J 2018, 'Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve', Circulation Journal, vol. 82, no. 1, pp. 289-292. https://doi.org/10.1253/circj.CJ-17-0851

@article{b2249337b08a477ab0291076e0aec127,

title = "Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve",

abstract = "Background: The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve. Methods and Results: We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events. Conclusions: Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.",

keywords = "Degenerated bioprosthesis, Transcatheter aortic valve implantation, Valve-in-valve",

author = "Kizuku Yamashita and Tomoyuki Fujita and Satsuki Fukushima and Yusuke Shimahara and Yuta Kume and Yorihiko Matsumoto and Naonori Kawamoto and Tatsuro Hitsumoto and Nobuyasu Ito and Yasuhiro Hamatani and Atsushi Okada and Hiroyuki Takahama and Makoto Amaki and Takuya Hasegawa and Yasuo Sugano and Hideaki Kanzaki and Toshihisa Anzai and Satoshi Yasuda and Junjiro Kobayashi",

year = "2018",

doi = "10.1253/circj.CJ-17-0851",

language = "English",

volume = "82",

pages = "289--292",

journal = "Circulation Journal",

issn = "1346-9843",

publisher = "Japanese Circulation Society",

number = "1",

}

TY - JOUR

T1 - Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve

AU - Yamashita, Kizuku

AU - Fujita, Tomoyuki

AU - Fukushima, Satsuki

AU - Shimahara, Yusuke

AU - Kume, Yuta

AU - Matsumoto, Yorihiko

AU - Kawamoto, Naonori

AU - Hitsumoto, Tatsuro

AU - Ito, Nobuyasu

AU - Hamatani, Yasuhiro

AU - Okada, Atsushi

AU - Takahama, Hiroyuki

AU - Amaki, Makoto

AU - Hasegawa, Takuya

AU - Sugano, Yasuo

AU - Kanzaki, Hideaki

AU - Anzai, Toshihisa

AU - Yasuda, Satoshi

AU - Kobayashi, Junjiro

PY - 2018

Y1 - 2018

N2 - Background: The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve. Methods and Results: We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events. Conclusions: Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.

AB - Background: The valve-in-valve procedure, in which a transcatheter heart valve (THV) is implanted over a prosthetic valve, has been shown to be safe and therapeutically effective, depending on the size of the replacement valve. Methods and Results: We report 3 cases of successful valve-in-valve procedure to replace a degenerated 19-mm stented prosthetic aortic valve. Balloon-expanding THVs were implanted: 20-mm in the 1st case and 23-mm in the next 2. Aortic stenosis was almost completely resolved in all patients, who recovered promptly and without cardiac adverse events. Conclusions: Using the valve-in-valve procedure for a 19-mm degenerated bioprosthesis was feasible and safe.

KW - Degenerated bioprosthesis

KW - Transcatheter aortic valve implantation

KW - Valve-in-valve

UR - http://www.scopus.com/inward/record.url?scp=85039745905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85039745905&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-17-0851

DO - 10.1253/circj.CJ-17-0851

M3 - Article

C2 - 29129879

AN - SCOPUS:85039745905

SN - 1346-9843

VL - 82

SP - 289

EP - 292

JO - Circulation Journal

JF - Circulation Journal

IS - 1

ER -

Transcatheter aortic valve implantation for degenerated 19-mm aortic bioprosthetic valve

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this